Moreover, radiomics features derived directly from tumor lesions may capture tumor heterogeneity more specifically and directly than indirect clinical parameters such as PD-L1 expression, BTS, and CRP, potentially accounting for their superior predictive efficacy. The gene discussed is CD274; the disease is neoplasm.